Scarica l'app Stockscreener
0.80
10.33%
0.0749
Dopo l'orario di chiusura:
.77
-0.03
-3.75%
Precedente Chiudi:
$0.7251
Aprire:
$0.73
Volume 24 ore:
408.65K
Relative Volume:
0.14
Capitalizzazione di mercato:
$62.22M
Reddito:
$11.03M
Utile/perdita netta:
$-44.24M
Rapporto P/E:
-1.2903
EPS:
-0.62
Flusso di cassa netto:
$-42.61M
1 W Prestazione:
+9.41%
1M Prestazione:
+8.17%
6M Prestazione:
-24.53%
1 anno Prestazione:
-20.95%
Intervallo 1D:
$0.73
$0.81
Intervallo di 1 settimana:
$0.68
$0.81
Portata 52W:
$0.5327
$1.90
Hyperfine Inc Stock (HYPR) Company Profile
Nome
Hyperfine Inc
Settore
Industria
Telefono
866-796-6767
Indirizzo
351 NEW WHITFIELD STREET, GUILFORD
Confronta HYPR con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
HYPR
Hyperfine Inc
|
0.80 | 62.22M | 11.03M | -44.24M | -42.61M | -0.62 |
|
ABT
Abbott Laboratories
|
134.44 | 233.36B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
104.32 | 147.06B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
395.28 | 145.64B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
88.39 | 112.76B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
76.79 | 44.46B | 5.54B | 4.18B | 623.10M | 7.00 |
Hyperfine Inc Stock (HYPR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2022-08-11 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2022-05-31 | Iniziato | Evercore ISI | Outperform |
| 2022-04-14 | Iniziato | Wells Fargo | Overweight |
Hyperfine Inc Borsa (HYPR) Ultime notizie
Hyperfine announces FDA clearance of Swoop system - MSN
Hyperfine (HYPR) Appoints New Chief Regulatory and Quality Officer | HYPR Stock News - GuruFocus
Hyperfine appoints two key executives to strengthen leadership team By Investing.com - Investing.com South Africa
Hyperfine Appoints Rob Fasciano as Chief Regulatory and Rafael O’Halloran as VP of Technology - citybiz
Hyperfine Announces Key Executive Appointments To Strengthen Its Leadership Position In AI-Powered Portable MRI - MarketScreener
Hyperfine Announces Key Executive Appointments to Strengthen its Leadership Position in AI-Powered Portable MRI - Business Wire
Hyperfine (NASDAQ:HYPR) Trading Down 2.8% – What’s Next? - Defense World
Hyperfine at Jefferies Healthcare: New MRI System Unveiled By Investing.com - Investing.com South Africa
Hyperfine Stock Rises After FDA Clears Next-Gen Swoop MRI System - MSN
Hyperfine at Jefferies Healthcare: New MRI System Unveiled - Investing.com
Hyperfine trading spiked on algorithms caching ‘AI,’ says B. Riley - Yahoo Finance
Hyperfine Wins FDA Nod for Next-Gen Swoop MRI with Optive AI - Medical Product Outsourcing
Hyperfine (HYPR) Sees Surge in Interest Following FDA Approval | HYPR Stock News - GuruFocus
Hyperfine unveils FDA-cleared next-gen portable MRI By Investing.com - Investing.com South Africa
Hyperfine Stock Is Soaring Higher Monday: What's Going On?Hyperfine (NASDAQ:HYPR) - Benzinga
Hyperfine wins FDA nod for next-gen Swoop powered by AI - MassDevice
Hyperfine unveils FDA-cleared next-gen portable MRI - Investing.com
Hyperfine (HYPR) Gains FDA Approval for New Portable MRI Scanner | HYPR Stock News - GuruFocus
Hyperfine Announces FDA Clearance Of A New Next-Generation Swoop System Powered By Optive Ai Software - marketscreener.com
Hyperfine Announces FDA Clearance of a New Next-Generation Swoop® System Powered by Optive AI™ Software, Delivering a Transformative Leap in Image Quality - Nasdaq
Hyperfine Receives FDA Clearance of Optive AI Software - Imaging Technology News
Hyperfine unveils advanced AI software for portable MRI By Investing.com - Investing.com South Africa
Hyperfine Gets FDA Clearance For Optive AI Software, Marking Major Upgrade To Swoop MRI Imaging - Nasdaq
Hyperfine Announces FDA Clearance of Optive AI™ Software, Introducing the Most Substantial Image Quality Improvement Ever for the Swoop® System - 01net
FDA OKs Hyperfine’s Optive AI Software for Swoop MR - Medical Product Outsourcing
Hyperfine Announces FDA Clearance Of Optive AI(TM) Software - marketscreener.com
Hyperfine announces FDA clearance of next-generation software - TipRanks
Hyperfine (HYPR) Gains FDA Clearance for Advanced Imaging Softwa - GuruFocus
Hyperfine unveils advanced AI software for portable MRI - Investing.com
Hyperfine Chairperson R. Scott Huennekens Resigns - MSN
Hyperfine, Inc. (HYPR) Reports Q1 Loss, Lags Revenue Estimates - MSN
Hyperfine Holds Annual Stockholders Meeting - TipRanks
B. Riley Has Optimistic Outlook of Hyperfine Q3 Earnings - Defense World
B. Riley Cuts Hyperfine (NASDAQ:HYPR) Price Target to $1.00 - Defense World
Hyperfine First Quarter 2025 Earnings: Misses Expectations - Yahoo Finance
Hyperfine Inc. Earnings Call: Transition and Growth - TipRanks
Hyperfine, Inc. to Participate in Upcoming Jefferies Global Healthcare Conference - 01net
Hyperfine (HYPR) Maintained as 'Buy' by B. Riley Securities, Price Target Lowered | HYPR Stock News - GuruFocus
Hyperfine price target lowered to $1 from $1.20 at B. Riley - TipRanks
B. Riley Reduces Price Target for Hyperfine (HYPR) After Sales M - GuruFocus
B. Riley Lowers Price Target on Hyperfine to $1 From $1.20, Keeps Buy Rating - marketscreener.com
Hyperfine Stock: A Deep Dive Into Analyst Perspectives (4 Ratings) - Benzinga
Wells Fargo Updates Price Target and Rating for HYPR | HYPR Stoc - GuruFocus
Hyperfine Inc Azioni (HYPR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Hyperfine Inc Azioni (HYPR) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| TEISSEYRE THOMAS | Chief Operating Officer |
Feb 18 '25 |
Sale |
1.20 |
3,237 |
3,884 |
84,990 |
| TEISSEYRE THOMAS | Chief Operating Officer |
Nov 18 '24 |
Sale |
0.85 |
2,800 |
2,380 |
88,227 |
| TEISSEYRE THOMAS | Chief Operating Officer |
Aug 16 '24 |
Sale |
1.05 |
2,746 |
2,883 |
91,027 |
0.19%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):